These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21276817)

  • 1. Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease.
    Penzes P; Vanleeuwen JE
    Brain Res Rev; 2011 Jun; 67(1-2):184-92. PubMed ID: 21276817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic Spines in Alzheimer's Disease: How the Actin Cytoskeleton Contributes to Synaptic Failure.
    Pelucchi S; Stringhi R; Marcello E
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptotoxicity in Alzheimer's Disease Involved a Dysregulation of Actin Cytoskeleton Dynamics through Cofilin 1 Phosphorylation.
    Rush T; Martinez-Hernandez J; Dollmeyer M; Frandemiche ML; Borel E; Boisseau S; Jacquier-Sarlin M; Buisson A
    J Neurosci; 2018 Nov; 38(48):10349-10361. PubMed ID: 30341179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aβ mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease.
    Kommaddi RP; Das D; Karunakaran S; Nanguneri S; Bapat D; Ray A; Shaw E; Bennett DA; Nair D; Ravindranath V
    J Neurosci; 2018 Jan; 38(5):1085-1099. PubMed ID: 29246925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic spine loss and synaptic alterations in Alzheimer's disease.
    Knobloch M; Mansuy IM
    Mol Neurobiol; 2008 Feb; 37(1):73-82. PubMed ID: 18438727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synapses and dendritic spines as pathogenic targets in Alzheimer's disease.
    Yu W; Lu B
    Neural Plast; 2012; 2012():247150. PubMed ID: 22474602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.
    Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL
    Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drebrin in Alzheimer's Disease.
    Ishizuka Y; Hanamura K
    Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
    Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic changes in Alzheimer's disease and its models.
    Pozueta J; Lefort R; Shelanski ML
    Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
    Nimmrich V; Ebert U
    Rev Neurosci; 2009; 20(1):1-12. PubMed ID: 19526730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spines.
    Yu W; Polepalli J; Wagh D; Rajadas J; Malenka R; Lu B
    Hum Mol Genet; 2012 Mar; 21(6):1384-90. PubMed ID: 22156579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the Postsynaptic Compartment of Excitatory Synapses by the Actin Cytoskeleton in Health and Its Disruption in Disease.
    Stefen H; Chaichim C; Power J; Fath T
    Neural Plast; 2016; 2016():2371970. PubMed ID: 27127658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta: a putative intra-spinal microtubule-depolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease.
    Mitsuyama F; Futatsugi Y; Okuya M; Karagiozov K; Peev N; Kato Y; Kanno T; Sano H; Koide T
    Ital J Anat Embryol; 2009; 114(2-3):109-20. PubMed ID: 20198823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
    Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease.
    Vargas LM; Cerpa W; Muñoz FJ; Zanlungo S; Alvarez AR
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1148-1159. PubMed ID: 29378302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
    Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
    Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-3-n-Butylphthalide improves synaptic and dendritic spine plasticity and ameliorates neurite pathology in Alzheimer's disease mouse model and cultured hippocampal neurons.
    Huang L; Lan J; Tang J; Kang Y; Feng X; Wu L; Peng Y
    Mol Neurobiol; 2021 Mar; 58(3):1260-1274. PubMed ID: 33146400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aβ Influences Cytoskeletal Signaling Cascades with Consequences to Alzheimer's Disease.
    Henriques AG; Oliveira JM; Carvalho LP; da Cruz E Silva OAB
    Mol Neurobiol; 2015 Dec; 52(3):1391-1407. PubMed ID: 25344315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ROCK, PAK, and Toll of synapses in Alzheimer's disease.
    Salminen A; Suuronen T; Kaarniranta K
    Biochem Biophys Res Commun; 2008 Jul; 371(4):587-90. PubMed ID: 18466762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.